Regulation of p53 in response to DNA damage
暂无分享,去创建一个
[1] C. Prives. Signaling to p53 Breaking the MDM2–p53 Circuit , 1998, Cell.
[2] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[3] Y Taya,et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.
[4] S. Jackson,et al. DNA repair: The Nijmegen breakage syndrome protein , 1998, Current Biology.
[5] M. Lovett,et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.
[6] M. Leppert,et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22–23 , 1988, Nature.
[7] J B Lawrence,et al. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. , 1994, Genes & development.
[8] T. Kouzarides. Histone acetylases and deacetylases in cell proliferation. , 1999, Current opinion in genetics & development.
[9] D. Meek,et al. p53 Is Phosphorylated in Vitro and in Vivo by an Ultraviolet Radiation-induced Protein Kinase Characteristic of the c-Jun Kinase, JNK1 (*) , 1995, The Journal of Biological Chemistry.
[10] Hirofumi Tanaka,et al. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 , 1997, FEBS letters.
[11] P. Herrlich,et al. DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation , 1999, Oncogene.
[12] A. Levine,et al. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[13] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[14] D. Livingston,et al. Binding and modulation of p53 by p300/CBP coactivators , 1997, Nature.
[15] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[16] John R. Yates,et al. Tra1p Is a Component of the Yeast Ada·Spt Transcriptional Regulatory Complexes* , 1998, The Journal of Biological Chemistry.
[17] P. Friedman,et al. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Levine,et al. Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.
[19] Y Taya,et al. DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.
[20] J R Yates,et al. The ATM-related cofactor Tra1 is a component of the purified SAGA complex. , 1998, Molecular cell.
[21] L. Donehower,et al. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. , 1996, Genes & development.
[22] P. Meltzer,et al. Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.
[23] K. Gardner,et al. Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.
[24] B. Vogelstein,et al. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[25] S. Schreiber,et al. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[26] A. Carr,et al. Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[27] T. Hupp,et al. DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site , 1998, Oncogene.
[28] S. Jackson,et al. The DNA-dependent protein kinase , 1999 .
[29] A. Deisseroth,et al. Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function. , 1994, Cancer research.
[30] C. Anderson,et al. Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen , 1990, Molecular and cellular biology.
[31] C. Prives,et al. Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases , 1995, Nature.
[32] Bert Vogelstein,et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.
[33] M. Kastan,et al. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization. , 1996, The American journal of pathology.
[34] D. Lane,et al. Allosteric activation of latent p53 tetramers , 1994, Current Biology.
[35] G. Wahl,et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.
[36] K. Kinzler,et al. 14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .
[37] P. Howley,et al. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation , 1997, Molecular and cellular biology.
[38] S. Benchimol,et al. The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. , 1993, The EMBO journal.
[39] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[40] D. George,et al. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. , 1991, The EMBO journal.
[41] A. Carr,et al. The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. , 1996, Genes & development.
[42] K. Sakaguchi,et al. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 , 1992, Molecular and cellular biology.
[43] Richard A. Ashmun,et al. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.
[44] W. Jongmans,et al. Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation , 1997, Molecular and cellular biology.
[45] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[46] A. Fornace,et al. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. , 1994, Cancer research.
[47] C. Prives,et al. Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminus , 1995, Cell.
[48] T. Halazonetis,et al. Identification of an additional negative regulatory region for p53 sequence-specific DNA binding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[49] D. Lane,et al. Small peptides activate the latent sequence-specific DNA binding function of p53 , 1995, Cell.
[50] A. Jochemsen,et al. Adenovirus E1A proteins inhibit activation of transcription by p53 , 1996, Molecular and cellular biology.
[51] A. Giaccia,et al. The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and p53 induction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[52] T. Halazonetis,et al. Wild‐type p53 adopts a ‘mutant’‐like conformation when bound to DNA. , 1993, The EMBO journal.
[53] Matthias Platzer,et al. Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome , 1998, Cell.
[54] M. Nussenzweig,et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination , 1996, Nature.
[55] Xin Lu,et al. Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes? , 1993, Cell.
[56] M. Grunstein. Histone acetylation in chromatin structure and transcription , 1997, Nature.
[57] A. Levine,et al. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. , 1994, Genes & development.
[58] F. Kashanchi,et al. Phosphorylation of p53 Serine 15 Increases Interaction with CBP* , 1998, The Journal of Biological Chemistry.
[59] V. Yamazaki,et al. Characterization of cell cycle checkpoint responses after ionizing radiation in Nijmegen breakage syndrome cells. , 1998, Cancer research.
[60] S. Elledge,et al. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. , 1998, Science.
[61] X. Chen,et al. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner , 1997, Molecular and cellular biology.
[62] T. Unger,et al. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2 , 1999, The EMBO journal.
[63] M. Cole,et al. The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.
[64] W. Deppert,et al. Negative feedback regulation of wild‐type p53 biosynthesis. , 1995 .
[65] M. Kubbutat,et al. Regulation of p53 Function and Stability by Phosphorylation , 1999, Molecular and Cellular Biology.
[66] S. Benchimol,et al. Participation of the human p53 3′UTR in translational repression and activation following γ‐irradiation , 1997, The EMBO journal.
[67] E. Stavridi,et al. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins , 1998, Nature Genetics.
[68] A. Levine,et al. The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.
[69] M. Hoekstra. Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family. , 1997, Current opinion in genetics & development.
[70] H. Piwnica-Worms,et al. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[71] S. Benchimol,et al. Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells , 1999, Oncogene.
[72] T. Unger,et al. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. , 1992, The EMBO journal.
[73] S. Berger,et al. p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage , 1999, Molecular and Cellular Biology.
[74] I. Takenaka,et al. Regulation of the Sequence-specific DNA Binding Function of p53 by Protein Kinase C and Protein Phosphatases (*) , 1995, The Journal of Biological Chemistry.
[75] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[76] M. Gatei,et al. Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells , 1999, Oncogene.
[77] Derrick E. Rancourt,et al. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage , 1998, Nature.
[78] S. Jackson,et al. The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen , 1993, Cell.
[79] K. Sakaguchi,et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.
[80] S. Schreiber,et al. Overexpression of a kinase‐inactive ATR protein causes sensitivity to DNA‐damaging agents and defects in cell cycle checkpoints , 1998, The EMBO journal.
[81] D. Livingston,et al. Association of p300 and CBP with simian virus 40 large T antigen , 1996, Molecular and cellular biology.
[82] W Eckhart,et al. Phosphorylation sites in the amino-terminal region of mouse p53. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[83] Wei Gu,et al. Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.
[84] A. Levine,et al. Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[85] A. Levine,et al. Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6 , 1998, Molecular and Cellular Biology.
[86] K. Muegge,et al. p53-dependent apoptosis and transcription of p21waf/cip1/sdi1 in SCID mice following gamma-irradiation. , 1997, Biochimie.
[87] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[88] Yoichi Taya,et al. DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.
[89] W. Maltzman,et al. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.
[90] B. Groner,et al. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain , 1997, Nature Medicine.
[91] J. Danska,et al. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. , 1996, Genes & development.
[92] Y. Shiloh,et al. ATM: from gene to function. , 1998, Human molecular genetics.
[93] D. Lane,et al. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding , 1997, Oncogene.
[94] Wei Gu,et al. Synergistic activation of transcription by CBP and p53 , 1997, Nature.
[95] P. Howley,et al. In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.
[96] G. Wahl,et al. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[97] Y Taya,et al. DNA damage‐inducible phosphorylation of p53 at N‐terminal sites including a novel site, Ser20, requires tetramerization , 1999, The EMBO journal.
[98] A. Giaccia,et al. The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.
[99] C. Anderson,et al. DNA damage and the DNA-activated protein kinase. , 1993, Trends in biochemical sciences.
[100] F. Alt,et al. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. , 1997, Immunity.
[101] G. Chu,et al. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. , 1997, Cancer research.
[102] V. Adler,et al. Mdm2 association with p53 targets its ubiquitination , 1998, Oncogene.
[103] Yoichi Taya,et al. ATM associates with and phosphorylates p53: mapping the region of interaction , 1999, Nature Genetics.
[104] Functional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation , 1998 .
[105] Michael Wolfe,et al. Parallelizing compilers , 1996, CSUR.
[106] A. Blasina,et al. A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase , 1999, Current Biology.
[107] D. Lane,et al. Regulation of the specific DNA binding function of p53 , 1992, Cell.
[108] A. Toker,et al. Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.
[109] John R Yates,et al. The hMre11/hRad50 Protein Complex and Nijmegen Breakage Syndrome: Linkage of Double-Strand Break Repair to the Cellular DNA Damage Response , 1998, Cell.
[110] J. Qin,et al. The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. , 1998, Molecular cell.
[111] T. Jacks,et al. Mutations in the p53 and SCID genes cooperate in tumorigenesis. , 1996, Genes & development.
[112] K. Chrzanowska,et al. Radiation induction of p53 in cells from Nijmegen breakage syndrome is defective but not similar to ataxia-telangiectasia. , 1998, Biochemical and biophysical research communications.
[113] A. Levine,et al. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[114] A. Carr,et al. The Schizosaccharomyces pombe rad3 checkpoint gene. , 1996, The EMBO journal.
[115] Yusuke Nakamura,et al. Positional cloning of the gene for Nijmegen breakage syndrome , 1998, Nature Genetics.
[116] K. Vousden,et al. Transcriptional activation by p53 correlates with suppression of growth but not transformation , 1994, Cell.
[117] D. Grunwald,et al. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[118] D. Meek,et al. Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation. , 1996, Nucleic acids research.
[119] Y Taya,et al. A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.
[120] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[121] M. Oren,et al. mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.
[122] A. Levine,et al. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches , 1995, Cell.